Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47,601,550
-
Total 13F shares
-
33,417,334
-
Share change
-
-3,981,641
-
Total reported value
-
$60,814,684
-
Price per share
-
$1.82
-
Number of holders
-
49
-
Value change
-
-$15,060,697
-
Number of buys
-
22
-
Number of sells
-
28
Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q3 2022
As of 30 Sep 2022,
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,417,334 shares.
The largest 10 holders included
BVF INC/IL, Bellevue Group AG, Soleus Capital Management, L.P., Avidity Partners Management LP, MORGAN STANLEY, EVENTIDE ASSET MANAGEMENT, LLC, PFM Health Sciences, LP, RTW INVESTMENTS, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., and Frazier Life Sciences Management, L.P..
This page lists
49
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.